Opportunities and limitations of genetic analysis of hypertensive rat strains

Journal of Hypertension

Volumn 27, Issue 6, 2009, Pages 1129-1133

  Saavedra, Juan M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; BLOOD VESSEL REACTIVITY; DAHL SALT SENSITIVE RAT; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC MARKER; GENOTYPE; HYPERTENSION; LYON HYPERTENSIVE RAT; MILAN HYPERTENSIVE RAT; NEW ZEALAND GENETICALLY HYPERTENSIVE RAT; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; RAT STRAIN; SABRA HYPERTENSIVE RAT; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM EXCRETION; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC TONE; WISTAR KYOTO RAT;

EID: 67649671827     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832bb832     Document Type: Note

References (70)

1. Garcia EA, Newhouse S, Caulfield MJ, Munroe PB. Genes and hypertension. Curr Pharm Des 2003; 9:1679-1689.
2. Lalouel JM, Rohrwasser A. Genetic susceptibility to essential hypertension: insight from angiotensinogen. Hypertension 2007; 49:597-603.
3. Freely associating. Nat Genet 1999; 22:1-2.
4. Strohman R. Epigenesis: the missing beat in biotechnology? Biotechnology (NY) 1994; 12:156-164.
5. Saavedra JM. Studies on genes and hypertension: a daunting task. J Hypertens 2005; 23:929-932.
6. Saavedra JM. The challenge of genetic studies in hypertension. Circ Res 2007; 100:1389-1393.
7. Harrison M, Maresso K, Broeckel U. Genetic determinants of hypertension: an update. Curr Hypertens Rep 2008; 10:488-495.
8. Lalouel JM, Rohrwasser A. Power and replication in case-control studies. Am J Hypertens 2002; 15:201-205.
9. Cowley AW Jr. The genetic dissection of essential hypertension. Nat Rev Genet 2006; 7:829-840.
10. McBride MW, Graham D, Delles C, Dominiczak AF. Functional genomics in hypertension. Curr Opin Nephrol Hypertens 2006; 15:145-451.
11. Kardia SL. Context-dependent genetic effects in hypertension. Curr Hypertens Rep 2000; 2:32-38.
12. Farahani P, Dolovich L, Levine M. Exploring design-related bias in clinical studies on receptor genetic polymorphism of hypertension. J Clin Epidemiol 2007; 60:1-7.
13. Luft FC. Geneticism of essential hypertension. Hypertension 2004; 43:1155-1159.
14. Mondry A, Loh M, Liu P, Zhu AL, Nagel M. Polymorphisms of the insertion/deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data. BMC Nephrol 2005; 6:1-11.
15. Samani NJ. Genome scans for hypertension and blood pressure regulation. Am J Hypertens 2003; 16:167-171.
16. Dominiczak AF, Graham D, McBride MW, Brain NJ, Lee WK, Charchar FJ, et al. Corcoran lecture. Cardiovascular genomics and oxidative stress. Hypertension 2005; 45:636-642.
17. Delles C, McBride MW, Padmanabhan S, Dominiczak AF. The genetics of cardiovascular disease. Trends Endocrinol Metab 2008; 19:309-316.
18. Pravenec M, Kren V. Genetic analysis of complex cardiovascular traits in the spontaneously hypertensive rat. Exp Physiol 2005; 90:273-276.
19. Nabika T, Cui Z, Masuda J. The stroke-prone spontaneously hypertensive rat: how good is it as a model for cerebrovascular diseases? Cell Mol Neurobiol 2004; 24:639-646.
20. Kato N. Genetic analysis in Dahl salt-sensitive rats. Clin Exp Pharmacol Physiol 1999; 26:539-540.
21. Ferrari P, Barber BR, Torielli L, Ferrandi M, Salardi S, Bianchi G. The Milan hypertensive rat as a model for studying cation transport abnormality in genetic hypertension. Hypertension 1987; 10 (P t 2):I32-I36.
22. Song J, Kost CK Jr, Martin DS. Androgens augment renal vascular responses to ANG II in New Zealand genetically hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2006; 290:R1608-R1615.
23. Yagil C, Sapojnikov M, Wechsler A, Korol A, Yagil Y. Genetic dissection of proteinuria in the Sabra rat. Physiol Genomics 2006; 25:121-133.
24. Sassard J, Lo M, Liu KL. Lyon genetically hypertensive rats: an animal model of 'low renin hypertension'. Acta Pharmacol Sin 2003; 24:1-6.
25. Clark JS, Jeffs B, Davidson AO, Lee WK, Anderson NH, Bihorau MT, et al. Quantitative trait loci in genetically hypertensive rats. Possible sex specificity. Hypertension 1996; 28:898-906.
26. Dubay C, Vincent M, Samani NJ, Hilbert P, Kaiser MA, Beressi JP, et al. Genetic determinants of diastolic and pulse pressure map to different loci in Lyon hypertensive rats. Nat Genet 1993; 3:354-357.
27. Garrett MR, Dene H, Walder R, Zhang QY, Cicila GT, Assadnia S, et al. Genome scan and congenic strains for blood pressure QTL using Dahl salt-sensitive rats. Genome Res 1998; 8:711-723.
28. Hilbert P, Lindpaintner K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, et al. Chromosomal mapping of two genetic loci associated with bloodpressure regulation in hereditary hypertensive rats. Nature 1991; 353:521-529.
29. Jacob HJ, Lindpaintner K, Lincoln SE, Kusumi K, Bunker RK, Mao YP, et al. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 1991; 67:213-224.
30. Schork NJ, Krieger JE, Trolliet MR, Franchini KG, Koike G, Krieger EM, et al. A biometrical genome search in rats reveals the multigenic basis of blood pressure variation. Genome Res 1995; 5:164-172.
31. Liu KL. Regulation of renal medullary circulation by the renin-angiotensin system in genetically hypertensive rats. Clin Exp Pharmacol Physiol 2009 Feb 10 [Epub ahead of print]
32. Horie R, Kihara M, Lovenberg W, Ben-Ishay D, Bianchi G, Iwai J, et al. Comparison of various genetic hypertensive rat strains. J Hypertens Suppl 1986; 4:S11-S14.
33. Heran BS, Wong MM, Heran IK, Wright JM. Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension. Cochrane Database Syst Rev 2008:CD003823.
34. Heran BS, Wong MM, Heran IK, Wright JM. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension. Cochrane Database Syst Rev 2008:CD003822.
35. Ruilope LM, Jakobsen A, Heroys J, Ralph A, Rees T, Shaw M. Prospects for renovascular protection by more aggressive renin-angiotensin system control. Medscape J Med 2008; 10 (Suppl):S5.
36. Baumann M, Janssen BJ, Hermans JJ, Peutz-Kootstra C, Witzke O, Smits JF, Struijker Boudier HA. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age. J Hypertens 2007; 25:207-215.
37. Julien C, Bertolino S, Medeiros IA, Barres C, Sassard J. Renin secretion in Lyon hypertensive rats. Clin Exp Hypertens 1997; 19:699-711.
38. Saavedra JM, Correa FM, Plunkett LM, Israel A, Kurihara M, Shigematsu K. Binding of angiotensin and atrial natriuretic peptide in brain of hypertensive rats. Nature 1986; 320:758-760.
39. Saavedra JM. Brain and pituitary angiotensin. Endocr Rev 1992; 13:329-380.
40. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86:747-803.
41. Stoll M, Kwitek-Black AE, Cowley AW Jr, Harris EL, Harrap SB, Krieger JE, et al. New target regions for human hypertension via comparative genomics. Genome Res 2000; 10:473-482.
42. Gilibert S, Bataillard A, Nussberger J, Sassard J, Kwitek AE. Implication of chromosome 13 on hypertension and associated disorders in Lyon hypertensive (LH) rats. J Hypertens 2009; 27:1129-1133.
43. Bilusic M, Bataillard A, Tschannen MR, Gao L, Barreto NE, Vincent M, et al. Mapping the genetic determinants of hypertension, metabolic diseases, and related phenotypes in the Lyon hypertensive rat. Hypertension 2004; 44:695-701.
44. Sautel M, Sacquet J, Vincent M, Sassard J. Brain and peripheral noradrenergic neuron activity in developing genetically hypertensive rats of the Lyon strain. Clin Exp Hypertens A 1988; 10 (Suppl 1):423-429.
45. Lantelme P, Lo M, Sassard J. Renin-angiotensin system in two genetically normotensive strains of Lyon rats. Am J Hypertens 2000; 13:283-289.
46. Aguilar F, Lo M, Claustrat B, Saez JM, Sassard J, Li JY. Hypersensitivity of the adrenal cortex to trophic and secretory effects of angiotensin II in Lyon genetically-hypertensive rats. Hypertension 2004; 43:87-93.
47. Liu KL, Aissa AH, Benzoni D, Sassard J. Renal thromboxane A2 synthesis in the Lyon hypertensive rat. Fundam Clin Pharmacol 1992; 6:343-351.
48. Florin M, Lo M, Liu KL, Sassard J. Salt sensitivity in genetically hypertensive rats of the Lyon strain. Kidney Int 2001; 59:1865-1872.
49. Vincent M, Boussaïri EH, Cartier R, Lo M, Sassolas A, Cerutti C, et al. High blood pressure and metabolic disorders are associated in the Lyon hypertensive rat. J Hypertens 1993; 11:1179-1185.
50. Lee NH. Physiogenomic strategies and resources to associate genes with rat models of heart, lung and blood disorders. Exp Physiol 2007; 92:992-1002.
51. Aneas I, Rodrigues MV, Pauletti BA, Silva GJ, Carmona R, Cardoso L, et al. Congenic strains provide evidence that four mapped loci in chromosomes 2, 4, and 1 6 influence hypertension in the SHR. Physiol Genomics 2009; 37:52-57.
52. Bilusic M, Moreno C, Barreto NE, Tschannen MR, Harris EL, Porteous WK, et al. Genetically hypertensive Brown Norway congenic rat strains suggest intermediate traits underlying genetic hypertension. Croat Med J 2008; 49:586-599.
53. Gilibert S, Kwitek AE, Hubner N, Tschannen M, Jacob HJ, Sassard J, Bataillard A. Effects of chromosome 1 7 on features of the metabolic syndrome in the Lyon hypertensive rat. Physiol Genomics 2008; 33:212-217.
54. Drenjancevic-Peric I, Phillips SA, Falck JR, Lombard JH. Restoration of normal vascular relaxation mechanisms in cerebral arteries by chromosomal substitution in consomic SS.13BN rats. Am J Physiol Heart Circ Physiol 2005; 289:H188-H195.
55. Mattson DL, Dwinell MR, Greene AS, Kwitek AE, Roman RJ, Jacob HJ, Cowley AW Jr. Chromosome substitution reveals the genetic basis of Dahl salt-sensitive hypertension and renal disease. Am J Physiol Renal Physiol 2008; 295:F837-F842.
56. Kwitek AE, Jacob HJ, Baker JE, Dwinell MR, Forster HV, Greene AS, et al. BN phenome: detailed characterization of the cardiovascular, renal, and pulmonary systems of the sequenced rat. Physiol Genomics 2006; 25:303-313.
57. Rat Genome Sequencing Project Consortium. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 2004; 428: 493-521.
58. Cowley AW Jr, Roman RJ, Kaldunski ML, Dumas P, Dickhout JG, Greene AS, Jacob HJ. Brown Norway chromosome 13 confers protection from high salt to consomic Dahl S rat. Hypertension 2001; 37 (Part 2):456-461.
59. Moreno C, Kaldunski ML, Wang T, Roman RJ, Greene AS, Lazar J, et al. Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat. Physiol Genomics 2007; 31:228-235.
60. Zeng C, Armando I, Luo Y, Eisner GM, Felder RA, Jose PA. Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol 2008; 294:H551 -H569.
61. Felder RA, Jose PA. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol 2006; 2:637-650.
62. Inagami T, Eguchi S, Numaguchi K, Motley ED, Tang H, Matsumoto T, Yamakawa T. Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases. J Am Soc Nephrol 1999; 10 (Suppl 11):S57-S61.
63. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377:748-750.
64. Siragy HM, Inagami T, Ichiki T, Carey RM. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A 1999; 96:6506-6510.
65. Tanaka M, Tsuchida S, Imai T, Fujii N, Miyazaki H, Ichiki T, et al. Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. Biochem Biophys Res Commun 1999; 258:194-198.
66. Saavedra JM, Häuser W, Ciuffo G, Egidy G, Hoe KL, Jöhren O, et al. Increased AT(1) receptor expression and mRNA in kidney glomeruli of AT(2) receptor gene-disrupted mice. Am J Physiol Renal Physiol 2001; 280:F71-F78.
67. Saavedra JM, Armando I, Terrón JA, Falcón-Neri A, Jöhren O, Häuser W, Inagami T. Increased AT(1) receptors in adrenal gland of AT(2) receptor gene-disrupted mice. Regul Pept 2001; 102:41-47.
68. Armando I, Terrón JA, Falcón-Neri A, Takeshi I, Häuser W, Inagami T, Saavedra JM. Increased angiotensin II AT(1) receptor expression in paraventricular nucleus and hypothalamic-pituitary-adrenal axis stimulation in AT(2) receptor gene disrupted mice. Neuroendocrinology 2002; 76:137-147.
69. Lee SJ, Cicila GT. Functional genomics in rat models of hypertension: using differential expression and congenic strains to identify and evaluate candidate genes. Crit Rev Eukaryot Gene Expr 2002; 12:297-31 6.
70. Malek RL, Wang H-y, Kwitek AE, Greene AS, Bhagabati N, Borchardt G, et al. Physiogenomic resources for rat models of heart, lung and blood disorders. Nat Genet 2006; 38:234-239.